NEW YORK (GenomeWeb News) – The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and MRM Proteomics said today that they are collaborating with the Jain Foundation on research into biomarkers for muscular dystrophy.

Specifically, the parties will look for blood-based markers for a rare form of the disease called Limb-girdle muscular dystrophy 2B or Miyoshi Myopathy, which is caused by mutations in the gene encoding the protein dysferlin.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.